Does InspireMD, Inc. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores InspireMD, Inc. (NSPR) 22.8 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 10, returns on capital 0, balance-sheet safety 55, capital discipline 44.

Is NSPR stock trading below its intrinsic value?

Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $54.03 per share versus a recent price of $0.70 — 99% below value. This is an educational estimate computed from primary SEC filings, not investment advice.

How has NSPR's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 22.8 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

InspireMD, Inc.

NSPR · Healthcare · $30.5M mkt cap · FY2025 filings · No moat ·

Doesn't clear the bar

No moat

The four filters

Pricing power10

Median gross margin 21.3% over 10y, variable.

Returns on capital0

Median ROIC -84.7%, above the 9% hurdle in 0% of years.

Balance-sheet safety55

Net cash position — no leverage risk.

Capital discipline44

Owner earnings trend unclear, share count n/a.

Margin of safety

Above valueOn sale

99% below value

Owner earnings (normalized): $211.7M
Est. intrinsic value / share: $54.03
Recent price: $0.70
Discount to value: 99% below value

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for NSPR yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale22.8 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — NSPR has read No moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#388 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#386CELU Celularity Inc.23.0 out of 100, No moatNo moat
#387CHUC CHARLIE’S HOLDINGS, INC.22.9 out of 100, No moatNo moat
#389BKD BROOKDALE SENIOR LIVING INC.22.7 out of 100, No moatNo moat
#390TKNO ALPHA TEKNOVA, INC.22.6 out of 100, No moatNo moat

Compare NSPR with its nearest peers →All Healthcare companies on the Index →

Common questions about NSPR

Does InspireMD, Inc. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores InspireMD, Inc. (NSPR) 22.8 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 10, returns on capital 0, balance-sheet safety 55, capital discipline 44.
Is NSPR stock trading below its intrinsic value?: Against a deliberately conservative owner-earnings model (9% discount rate, 0% assumed growth, capped at 4%), estimated intrinsic value is $54.03 per share versus a recent price of $0.70 — 99% below value. This is an educational estimate computed from primary SEC filings, not investment advice.
How has NSPR's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 22.8 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows NSPR’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/NSPR"
  width="340" height="150" style="border:0"
  title="NSPR Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell NSPR. See the disclaimer.